Scarica l'app Stockscreener
0.37
1.37%
0.005
Dopo l'orario di chiusura:
.38
0.01
+2.70%
Gossamer Bio Inc Borsa (GOSS) Ultime notizie
GOSS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Gossamer Bio, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Stop Loss: Is Gossamer Bio Inc part of any ETFMarket Performance Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
GOSS INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026 - Sahm
Gossamer Bio Lawsuit: Investors Allege Misleading Statements Ahead of Failed PAH Trial - tipranks.com
Securities Fraud Investigation Into Gossamer Bio, Inc. (GOSS) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm - lincolnjournal.com
Gossamer Bio, Inc. (GOSS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - lincolnjournal.com
Investors Seek Lead in Gossamer Bio Securities Fraud Lawsuit - National Today
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
GOSS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Gossamer Bio, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Gossamer Bio, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsGOSS - bitget.com
GOSS Investors Invited to Lead Securities Fraud Lawsuit Against Gossamer Bio - National Today
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gossamer Bio, Inc. of Class Action Lawsuit and Upcoming DeadlinesGOSS - ChartMill
GOSS Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Filed Against Gossamer Bio, Inc. - PR Newswire
Securities Fraud Investigation Into Gossamer Bio, Inc. (GOSS) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz - lincolnjournal.com
Bronstein, Gewirtz & Grossman LLC Urges Gossamer Bio, Inc. - GlobeNewswire
GOSS SEC FilingsGossamer Bio 10-K, 10-Q, 8-K Forms - stocktitan.net
GOSS Stock Price, Quote & Chart | GOSSAMER BIO INC (NASDAQ:GOSS) - ChartMill
Gossamer Bio, Inc. (4GB.MU) stock price, news, quote and history - Yahoo Finance Australia
Bragar Eagel & Squire, P.C. Announces that a Class Action - GlobeNewswire
Investor Notice: Robbins LLP Informs Investors of the Gossamer Bio, Inc. Class Action Lawsuit - The AI Journal
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Gossamer Bio, Inc. (GOSS) - GlobeNewswire Inc.
GOSS DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Gossamer - GlobeNewswire
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Gossamer Bio, Inc. (GOSS) Investors – ... - Caledonian Record
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire
GOSS: Announces Topline Results for Phase 3 PROSERA Trial -- LEVI & KORSINSKY, LLP - PR Newswire
Trading Action: Is Gossamer Bio Inc stock a smart retirement pick2026 Historical Comparison & Precise Entry and Exit Recommendations - baoquankhu1.vn
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Gossamer Bio, Inc. Securities and Sets a Lead Plaintiff Deadline of June 1, 2026 - GlobeNewswire
683 Capital Management, LLC Reduces Stake in Gossamer Bio Inc - GuruFocus
Gossamer Bio (GOSS) price target decreased by 53.60% to 4.44 - msn.com
Why Bullish Analysts Still See Major Upside in Gossamer Bio (GOSS) After PROSERA Setback - insidermonkey.com
Gossamer Bio Receives 'Hold' Rating from Analysts - National Today
Gossamer Bio, Inc. (NASDAQ:GOSS) Receives Consensus Recommendation of "Hold" from Brokerages - marketbeat.com
10 Penny Stocks with Potential to Rise 1000 Percent - Insider Monkey
Vanguard reports zero beneficial holdings in Gossamer Bio (NASDAQ: GOSS) - Stock Titan
Cantor Fitzgerald downgrades Gossamer Bio (GOSS) - MSN
GOSS (Gossamer Bio) PB Ratio : (As of Mar. 26, 2026) - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc.GOSS - PR Newswire
GOSS: Management Optimistic About Topline Results -- LEVI & KORSINSKY, LLP Investigates After Trial Fails - GlobeNewswire
Layoff Tracker: Takeda Restructuring Will Affect Workforce, Could Include Layoffs - BioSpace
Legal Scrutiny Intensifies for Gossamer Bio Following Clinical Trial Setback () - aktiencheck.de
Options Flow: Is Gossamer Bio Inc a stock for growth or value investorsPortfolio Performance Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn
GOSS Technical Analysis | Trend, Signals & Chart Patterns | GOSSAMER BIO INC (NASDAQ:GOSS) - ChartMill
Gossamer Bio (GOSS) continues downtrend despite impressive revenue - MSN
Setup Watch: Should I set a stop loss on Gossamer Bio IncTrade Entry Report & Smart Investment Allocation Insights - baoquankhu1.vn
Gossamer Bio (GOSS) Continues Downtrend Despite Impressive Revenue - Insider Monkey
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Gossamer Bio, Inc. – GOSS - ChartMill
683 Capital (GOSS) reports 3.90% position including exercisable warrants - Stock Titan
Gossamer Bio (GOSS) Downgraded to Neutral by Cantor Fitzgerald | - gurufocus.com
Gossamer Bio downgraded by Cantor on unclear regulatory path for seralutinib - Seeking Alpha
This Box Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Benzinga
Cantor Fitzgerald Reiterates "Neutral" Rating for Gossamer Bio (NASDAQ:GOSS) - MarketBeat
Cantor Fitzgerald cuts Gossamer Bio stock rating after trial miss By Investing.com - Investing.com South Africa
Cantor Fitzgerald cuts Gossamer Bio stock rating after trial miss - Investing.com UK
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):